Patents by Inventor Robert Joseph Thomas

Robert Joseph Thomas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10286168
    Abstract: An improvement for existing breathing therapy machines which allows the machine to determine a patient's dominant respiratory phenotype using an auto-titration mode and flow sensor.
    Type: Grant
    Filed: July 17, 2014
    Date of Patent: May 14, 2019
    Assignee: DEVILBISS HEALTHCARE LLC
    Inventors: Michael B. Knepper, James P. Froehlich, Robert Joseph Thomas, Joseph J. Boring
  • Patent number: 9931483
    Abstract: An improvement to a breathing therapy machine to detect and rate occurrences of periodic breathing and to alter the therapy delivered to a user of the device based on the rating.
    Type: Grant
    Filed: May 28, 2014
    Date of Patent: April 3, 2018
    Assignee: DEVILBISS HEALTCARE LLC
    Inventors: Michael Knepper, Robert Joseph Thomas, Wim Martens
  • Publication number: 20160015917
    Abstract: An improvement for existing breathing therapy machines which allows the machine to determine a patient's dominant respiratory phenotype using an auto-titration mode and flow sensor.
    Type: Application
    Filed: July 17, 2014
    Publication date: January 21, 2016
    Applicant: DEVILBISS HEALTHCARE LLC
    Inventors: Michael B. Knepper, James P. Froehlich, Robert Joseph Thomas, Joseph J. Boring
  • Publication number: 20150343161
    Abstract: An improvement to a breathing therapy machine to detect and rate occurrences of periodic breathing and to alter the therapy delivered to a user of the device based on the rating.
    Type: Application
    Filed: May 28, 2014
    Publication date: December 3, 2015
    Applicant: DEVILBISS HEALTHCARE LLC
    Inventors: Michael Knepper, Robert Joseph Thomas, Wim Martens
  • Patent number: 8403848
    Abstract: An assessment of sleep quality and sleep disordered breathing is determined from the cardiopulmonary coupling between two physiological data series. In an embodiment, an R-R interval series is derived from an electrocardiogram (ECG) signal. The normal beats from the R-R interval series are extracted to produce a normal-to-normal (NN) interval series. The amplitude variations in the QRS complex are used to extract to a surrogate respiration signal (i.e., ECG-derived respiration (EDR)) that is associated with the NN interval series. The two series are corrected to remove outliers, and resampled. The cross-spectral power and coherence of the two resampled signals are calculated over a plurality of coherence windows. For each coherence window, the product of the coherence and cross-spectral power is used to calculate coherent cross power. Using the appropriate thresholds for the coherent cross power, the proportion of sleep spent in CAP, non-CAP, and wake and/or REM are determined.
    Type: Grant
    Filed: January 23, 2008
    Date of Patent: March 26, 2013
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Joseph E. Mietus, Chung-Kang Peng, Robert Joseph Thomas, Ary L. Goldberger
  • Patent number: 8401626
    Abstract: An assessment of sleep quality and sleep disordered breathing is determined from cardiopulmonary coupling between two physiological data series. An R-R interval series is derived from an electrocardiogram (ECG) signal. The normal beats from the R-R interval series are extracted to produce a normal-to-normal interval series. The amplitude variations in the QRS complex are used to extract a surrogate respiration signal (i.e., ECG-derived respiration) associated with the NN interval series. The two series are corrected to remove outliers, and resampled. The cross-spectral power and coherence of the two resampled signals are calculated over a plurality of coherence windows. For each coherence window, the product of the coherence and cross-spectral power is used to calculate coherent cross-power. Using the appropriate thresholds for the coherent cross-power, the proportion of sleep spent in CAP, non-CAP, and wake and/or REM are determined.
    Type: Grant
    Filed: September 30, 2009
    Date of Patent: March 19, 2013
    Assignee: Beth Israel Deaconess Medical Center, Inc.
    Inventors: Joseph E. Mietus, Chung-Kang Peng, Robert Joseph Thomas, Ary L. Goldberger